Bill > HB1643

This bill modifies state law to create a legal framework for the therapeutic use of psilocybin, a psychedelic substance currently classified as a controlled substance. The legislation allows individuals 21 years and older who are experiencing specific medical conditions such as end-of-life care, post-traumatic stress disorder, major depressive disorder, or substance use disorders to legally acquire and use psilocybin under certain conditions. Users must obtain documentation from a physician or certified nurse practitioner, have a designated facilitator (who must have specific training in mental health and psilocybin-assisted therapy), ensure the psilocybin is laboratory tested, and limit their usage to 150 milligrams per twelve-month period. The bill provides legal protection for patients, healthcare providers, facilitators, and laboratories involved in psilocybin therapy, ensuring they cannot be criminally prosecuted or professionally sanctioned. Additionally, the legislation mandates confidentiality of patient information and establishes training requirements for facilitators, including a minimum of 30 hours of synchronous learning specific to psilocybin therapy. The bill aims to provide a regulated pathway for individuals to access potentially therapeutic psychedelic treatments while maintaining safety protocols and professional standards.

https://house.mo.gov/Bill.aspx?bill=HB1643&year=2026&code=R